A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer Article

keywords

  • CHEMORADIOTHERAPY
  • CISPLATIN
  • CONCURRENT RADIOTHERAPY
  • Life Sciences & Biomedicine
  • Oncology
  • Pharmacology & Pharmacy
  • STAGE-III
  • Science & Technology
  • TRIAL
  • gemcitabine
  • lung cancer
  • palliative radiation
  • phase I
  • radiosensitizers

Digital Object Identifier (DOI)

start page

  • 175

end page

  • 179

volume

  • 63

issue

  • 1